YAŞLILIKTA KARACİĞER HASTALIKLARI

1. Varanasi RV, Varanasi SC, Howell CD. Liver
diseases. Clin Geriatr Med 1999; 15: 559-570.
2. Wynne HA, Cope LH, Mutch E, Rawlins MD,
Woodhouse KW, James OF. The effect of age
upon liver volume and apparent liver blood flow
in healthy man. Hepatology 1989; 9: 297-301.
3. Rawlins MD, James OF, Williams FM, Wynne
H, Woodhouse KW. Age and the metabolism of
drugs. Q J Med 1987; 64: 545-547.
4. Greenblatt DJ, Sellers EM, Shader RI. Drug
therapy: drug disposition in old age. N Engl J
Med 1982; 306: 1081-1088.
5. Woodhouse KW, James OF. Hepatic drug metabolism
and ageing. Br Med Bull 1990; 46: 22-
35.
6. Vestal RE. Aging and determinants of hepatic
drug clearance. Hepatology 1989; 9: 331-334.
7. Einarsson K, Nilsell K, Leijd B, Angelin B. Influence
of age on secretion of cholesterol and
synthesis of bile acids by the liver. N Engl J
Med 1985; 313: 277-282.
8. Hilden M, Christoffersen P, Juhl E, Dalgaard
JB. Liver histology in a ’normal’ population--
examinations of 503 consecutive fatal traffic
casualties. Scand J Gastroenterol 1977; 12:
593-597.
9. Findor J, Perez V, Igartua EB, Giovanetti M,
Fioravantti N. Structure and ultrastructure of
the liver in aged persons. Acta Hepatogastroenterol
(Stuttg) 1973; 20: 200-204.
10. Popper H. Aginig and the liver. In Popper,
Schaffner F (eds). Progress in Liver Disease, vol
VIII, Orlnado: Grune, Stratton. 1986; 659-683.
11. Hale WE, Stewart RB, Marks RG. Haematological
and biochemical laboratory values in an
ambulatory elderly population: an analysis of
the effects of age, sex and drugs. Age Ageing
1983; 12: 275-284.
12. Van Dam J, Zeldis JB. Hepatic diseases in the
elderly. Gastroenterol Clin North Am 1990; 19:
459-472.
13. Mahon MM, James OF. Liver disease in the
elderly. J Clin Gastroenterol 1994; 18: 330-334.
14. Forbes A, Williams R. Increasing age--an important
adverse prognostic factor in hepatitis A
virus infection. J R Coll Physicians Lond 1988;
22: 237-239.
15. James OF. Parenchymal liver disease in the
elderly. Gut 1997; 41: 430-432.
16. Reeder BA, Halket PJ. An outbreak of hepatitis
B in a nursing home. CMAJ 1987; 137: 511-512.
17. Braconier JH, Nordenfelt E. Serum hepatitis at
a home for the aged. Scand J Infect Dis 1972; 4:
79-82.
18. Chiaramonte M, Floreani A, Naccarato R.
Hepatitis B virus infection in homes for the
aged. J Med Virol 1982; 9: 247-255.
19. Kondo Y, Tsukada K, Takeuchi T, Mitsui T,
Iwano K, Masuko K, et al. High carrier rate
after hepatitis B virus infection in the elderly.
Hepatology 1993; 18: 768-774.
20. Bernuau J, Goudeau A, Poynard T, Dubois F,
Lesage G, Yvonnet B, et al. Multivariate analysis
of prognostic factors in fulminant hepatitis
B. Hepatology 1986; 6: 648-651.
21. Takahashi Y, Kumada H, Shimizu M, Tanikawa
K, Kumashiro R, Omata M, et al. A multicenter
study on the prognosis of fulminant
viral hepatitis: early prediction for liver transplantation.
Hepatology 1994; 19: 1065-1071.
22. Floreani A, Bertin T, Soffiati G, Naccarato R,
Chiaramonte M. Are homes for the elderly still
a risk area for HBV infection? Eur J Epidemiol
1992; 8: 808-811.
23. Cook JM, Gualde N, Hessel L, Mounier M, Michel
JP, Denis F, et al. Alterations in the human
immune response to the hepatitis B vaccine
among the elderly. Cell Immunol 1987;
109: 89-96.
24. Katkov WN. Hepatitis vaccines. Med Clin
North Am 1996; 80: 1189-1200.
25. Marcus EL, Tur-Kaspa R. Viral hepatitis in
older adults. J Am Geriatr Soc 1997; 45: 755-
763.
26. Sarbah SA, Younossi ZM. Hepatitis C: an update
on the silent epidemic. J Clin Gastroenterol
2000; 30: 125-143.
27. Seeff LB. Natural history of hepatitis C. Am J
Med 1999; 107: 10-15.
28. Watson JP, Brind AM, Chapman CE, Bates CL,
Gould FK, Johnson SJ, et al. Hepatitis C virus:
epidemiology and genotypes in the north east of
England. Gut 1996; 38: 269-276.
29. Simmonds P, Mellor J, Craxi A, Sanchez-
Tapias JM, Alberti A, Prieto J, et al. Epidemiological,
clinical and therapeutic associations of
hepatitis C types in western European patients.
J Hepatol 1996; 24: 517-524.
30. Perez R, Pravia R, Linares A, Rodriguez M,
Lombrana JL, Suarez A, et al. Response related
factors in recombinant interferon alfa-2b treatment
of chronic hepatitis C. Gut 1993; 34: 139-
140.
31. Horiike N, Masumoto T, Nakanishi K, Michitaka
K, Kurose K, Ohkura I, et al. Interferon
therapy for patients more than 60 years of age
with chronic hepatitis C. J Gastroenterol Hepatol
1995; 10: 246-249.
32. Van Thiel DH, Friedlander L, Caraceni P,
Molloy PJ, Kania RJ. Treatment of hepatitis C
virus in elderly persons with interferon alpha. J
Gerontol A Biol Sci Med Sci 1995; 50: 330-333.
33. Bresci G, Del Corso L, Romanelli AM, Giuliano
G, Pentimone F. The use of recombinant interferon
alfa-2b in elderly patients with anti-HCVpositive
chronic active hepatitis. J Am Geriatr
Soc 1993; 41: 857-862.
34. Corwin A, Jarot K, Lubis I, Nasution K, Suparmawo
S, Sumardiati A, et al. Two years’ investigation
of epidemic hepatitis E virus transmission
in West Kalimantan (Borneo), Indonesia.
Trans R Soc Trop Med Hyg 1995; 89: 262-265.
35. Baillie S, Yelland C, Woodhouse KW. Hepatic
adverse drug reactions in the elderly. Adverse
Drug React Acute Poisoning Rev 1989; 8: 153-
163.
36. Moses A, Zahger D, Amir G. Cholestatic liver
injury after prolonged exposure to methyldopa.
Digestion 1989; 42: 57-60.
37. Tameda Y, Hamada M, Takase K, Nakano T,
Kosaka Y. Fulminant hepatic failure caused by
ecarazine hydrochloride (a hydralazine derivative).
Hepatology 1996; 23: 465-470.
38. Traverse JH, Swenson LJ, McBride JW. Acute
hepatic injury after treatment with diltiazem.
Am Heart J 1994; 127: 1636-1639.
39. Rinder HM, Love JC, Wexler R. Amiodarone
hepatotoxicity. N Engl J Med 1986; 314: 318-
319.
40. Menkes CJ. Renal and hepatic effects of
NSAIDs in the elderly. Scand J Rheumatol
Suppl 1989; 83: 11-13.
41. Adelizzi RA. Clinical implications of NSAID
pharmacokinetics: special populations, special
considerations. J Am Osteopath Assoc 1994; 94:
396-403.
42. Woo J, Chan HS. Therapeutic problems in the
management of elderly patients with tuberculosis.
Adverse Drug React Toxicol Rev 1992; 11:
13-18.
43. Snider DE Jr, Caras GJ. Isoniazid-associated
hepatitis deaths: a review of available information.
Am Rev Respir Dis 1992; 145: 494-497.
44. Hislop WS, Bouchier IA, Allan JG, Brunt PW,
Eastwood M, Finlayson ND, et al. Alcoholic
liver disease in Scotland and northeastern England:
presenting features in 510 patients. Q J
Med 1983; 52: 232-243.
45. Woodhouse KW, James OF. Alcoholic liver disease
in the elderly: presentation and outcome.
Age Ageing 1985; 14: 113-118.
46. Potter JF, James OF. Clinical features and
prognosis of alcoholic liver disease in respect of
advancing age. Gerontology 1987; 33: 380-387.
47. Wynne HA, Wood P, Herd B, Wright P, Rawlins
MD, James OF. The association of age with the
activity of alcohol dehydrogenase in human
liver. Age Ageing 1992; 21: 417-420.
48. Newton JL, Burt AD, Park JB, Mathew J, Bassendine
MF, James OF. Autoimmune hepatitis
in older patients. Age Ageing 1997; 26: 441-444.
49. Hislop WS, Hopwood D, Bouchier IA. Primary
biliary cirrhosis in elderly females. Age Ageing
1982; 11: 153-159.
50. Roll J, Boyer JL, Barry D, Klatskin G. The
prognostic importance of clinical and histologic
features in asymptomatic and symptomatic primary
biliary cirrhosis. N Engl J Med 1983; 308:
1-7.
51. Goudie BM, Burt AD, Macfarlane GJ, Boyle P,
Gillis CR, MacSween RN, et al. Risk factors
and prognosis in primary biliary cirrhosis. Am
J Gastroenterol 1989; 84: 713-716.
52. Hodgson SF, Dickson ER, Wahner HW, Johnson
KA, Mann KG, Riggs BL. Bone loss and
reduced osteoblast function in primary biliary
cirrhosis. Ann Intern Med 1985; 103: 855-860.
53. Mitchison HC, Lucey MR, Kelly PJ, Neuberger
JM, Williams R, James OF. Symptom development
and prognosis in primary biliary cirrhosis:
a study in two centers. Gastroenterology
1990; 99: 778-784.
54. Triger DR. Primary biliary cirrhosis: an epidemiological
study. Br Med J 1980; 281: 772-775.
55. Poupon RE, Balkau B, Eschwege E, Poupon R.
A multicenter, controlled trial of ursodiol for
the treatment of primary biliary cirrhosis.
UDCA-PBC Study Group. N Engl J Med 1991;
324: 1548-1554.
56. Poupon RE, Lindor KD, Cauch-Dudek K, Dickson
ER, Poupon R, Heathcote EJ. Combined
analysis of randomized controlled trials of ursodeoxycholic
acid in primary biliary cirrhosis.
Gastroenterology 1997; 113: 884-890.
57. Simon M, Brissot P. The genetics of haemochromatosis.
J Hepatol 1988; 6: 116-124.
58. Bomford A, Williams R. Long term results of
venesection therapy in idiopathic haemochromatosis.
Q J Med 1976; 45: 611-623.
59. Deugnier YM, Guyader D, Crantock L, Lopez
JM, Turlin B, Yaouanq J, et al. Primary liver
cancer in genetic hemochromatosis: a clinical,
pathological, and pathogenetic study of 54
cases. Gastroenterology 1993; 104: 228-234.
60. Niederau C, Fischer R, Purschel A, Stremmel
W, Haussinger D, Strohmeyer G. Long-term
survival in patients with hereditary hemochromatosis.
Gastroenterology 1996; 110: 1107-
1119.
61. Gitlin N, Serio KM. Ischemic hepatitis: widening
horizons. Am J Gastroenterol 1992; 87: 831-
836.
62. Sprung J, Levy PJ, Tabares AH, Gottlieb A,
Schoenwald PK, Olin JW. Ischemic liver dysfunction
after elective repair of infrarenal aor-
tic aneurysm: incidence and outcome. J Cardiothorac
Vasc Anesth 1998; 12: 507-511.
63. Mathurin P, Durand F, Ganne N, Mollo JL, Lebrec
D, Degott C, et al. Ischemic hepatitis due
to obstructive sleep apnea. Gastroenterology
1995; 109: 1682-1684.
64. Gourgoutis G, Das G. Gastrointestinal manifestations
of cocaine addiction. Int J Clin Pharmacol
Ther 1994; 32: 136-141.
65. Lefkowitch JH, Mendez L. Morphologic features
of hepatic injury in cardiac disease and
shock. J Hepatol 1986; 2: 313-327.
66. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL,
Wong J. Hepatic resection for hepatocellular
carcinoma. An audit of 343 patients. Ann Surg
1995; 221: 291-298.
67. Kahng KU, Roslyn JJ. Surgical issues for the
elderly patient with hepatobiliary disease. Surg
Clin North Am 1994; 74: 345-373.
68. Affronti J. Biliary disease in the elderly patient.
Clin Geriatr Med 1999; 15: 571-578.
69. Saunders K, Tompkins R, Longmire W Jr, Roslyn
J. Bile duct carcinoma in the elderly. A rationale
for surgical management. Arch Surg
1991; 126: 1186-1190.
70. National Institutes of Health Consensus Development
Conference Statement: liver transplantation--
June 20-23, 1983. Hepatology 1984; 4:
107-110.
71. Scheiner P, Emre S, Guy SR, Min A, Schwartz
ME, Miller CM. The older liver transplant candidate:
what are the limits? Liver Transpl Surg
1996; 2: 9-11.
72. Emre S, Mor E, Schwartz ME, Katz E, Acarli
K, Fukuzawa K, et al. Liver transplantation in
patients beyond age 60. Transplant Proc 1993;
25: 1075-1076.
73. Pirsch JD, Kalayoglu M, D’Alessandro AM,
Voss BJ, Armbrust MJ, Reed A, et al. Orthotopic
liver transplantation in patients 60
years of age and older. Transplantation 1991;
51: 431-433.
74. Stieber AC, Gordon RD, Todo S, Tzakis AG,
Fung JJ, Casavilla A, et al. Liver transplantation
in patients over sixty years of age. Transplantation
1991; 51: 271-273.
75. Dindzans VJ, Schade RR, Van Thiel DH. Medical
problems before and after transplantation.
Gastroenterol Clin North Am 1988; 17: 19-31.
76. Belle SH, Beringer KC, Detre KM. Recent findings
concerning liver transplantation in the
United States. Clin Transpl 1996; 15-29.
77. Bismuth H, Farges O, Castaing D, Samuel D,
Adam R, Johann M, et al. Evaluation of results
of liver transplantation: experience based on a
series of 1052 transplantations. Presse Med
1995; 24: 1106-1114.
78. Zetterman RK, Belle SH, Hoofnagle JH, Lawlor
S, Wei Y, Everhart J, et al. Age and liver transplantation:
a report of the Liver Transplantation
Database. Transplantation 1998; 66: 500-
506.